JAK2 transphosphorylates and is activated in response to Erythropoietin

Stable Identifier
R-HSA-9006332
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Upon binding EPO, the EPOR dimer changes conformation, resulting in activation of JAK2 associated with box 1 and box 2 of the cytoplasmic domain of each EPOR (inferred from mouse homologs). One JAK2 transphosphorylates 12 tyrosine residues of the other JAK2 thereby activating JAK2 to phosphorylate EPOR and other substrates (Arcasoy et al. 1999, Watowich et al. 1999, Erickson-Miller et al. 2000, and inferred from mouse homologs).

Literature References
PubMed ID Title Journal Year
11007921 Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation

Erickson-Miller, CL, Pelus, LM, Lord, KA

Stem Cells 2000
9923445 A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation

Arcasoy, MO, Harris, KW, Forget, BG

Exp. Hematol. 1999
10498627 Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state

Watowich, SS, Xie, X, Klingm├╝ller, U, Kere, J, Lindlof, M, Berglund, S, de la Chapelle, A

Blood 1999
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein tyrosine kinase activity of EPO:EPOR:JAK2:LYN:IRS2 [plasma membrane]
Physical Entity
Activity
Inferred From
Authored
Reviewed
Created